Publication:
Gut hormones and gut microbiota: implications for kidney function and hypertension

dc.contributor.coauthorAfşar, Barış
dc.contributor.coauthorVaziri, Nosratola D.
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorAslan, Gamze
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuauthorTarım, Kayhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T22:52:50Z
dc.date.issued2016
dc.description.abstractIncreased blood pressure (BP) and chronic kidney disease are two leading risk factors for cardiovascular disease. Increased sodium intake is one of the most important risk factors for development of hypertension. Recent data have shown that gut influences kidney function and BP by variety of mechanisms. Various hormones and peptides secreted from gut such as gastrin, glucocorticoids, Glucagon-like peptide-1 impact on kidney function and BP especially influencing sodium absorption from gut. These findings stimulate scientist to find new therapeutic options such as tenapanor for treatment of hypertension by blocking sodium absorption from gut. The gastrointestinal tract is also occupied by a huge community of microbes (micro-biome) that under normal condition has a symbiotic relationship with the host. Alterations in the structure and function of the gut microbiota have been shown to play a key role in the pathogenesis and complications of numerous diseases including hypertension. Based on these data, in this review, we provide a summary of the available data on the role of gut and gut microbiota in regulation of BP and kidney function.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.doi10.1016/j.jash.2016.10.007
dc.identifier.eissn1878-7436
dc.identifier.embargoN/A
dc.identifier.endpage961
dc.identifier.issn1933-1711
dc.identifier.issue12
dc.identifier.pubmed27865823
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85006132466
dc.identifier.startpage954
dc.identifier.urihttps://doi.org/10.1016/j.jash.2016.10.007
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7069
dc.identifier.volume10
dc.identifier.wos000390293000008
dc.keywordsIntestinal hormones
dc.keywordsKidney disease
dc.keywordsMicrobiota
dc.keywordsNa plus /H plus exchanger-3
dc.language.isoeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJournal of the American Society of Hypertension
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectCardiovascular system
dc.subjectCardiology
dc.titleGut hormones and gut microbiota: implications for kidney function and hypertension
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorAslan, Gamze
local.contributor.kuauthorTarım, Kayhan
local.contributor.kuauthorKanbay, Mehmet
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files